Referring directly to these trials and similar studies, the report indicated progress and hope for development in the search for effective Alzheimer’s prevention. “Thanks to advances in imaging and biomarkers that enable researchers to detect the earliest signs of Alzheimer’s-related brain changes,” the report stated, “we are entering an exciting new era of testing interventions across the disease spectrum.”
Both trials are currently seeking cognitively healthy but at-risk volunteers on which to test new drug therapies. Read the full report to learn more. If you are interested in partnering to fund Alzheimer’s research, contact us.